Because of their strong effects on cell survival and on synaptic function, neurotrophic factors (NTFs) have been hypothesized to be involved in some aspects of status epilepticus (SE) and in its possible consequences. This hypothesis has been explored mainly for 2 NTFs, namely fibroblast growth factor 2 (FGF-2) and brain-derived neurotrophic factor (BDNF). This article focuses on these 2 NTFs. I first summarize their biologic features and then describe existing evidence supporting their implication in SE and its outcomes. Available data support a direct implication of FGF-2 and BDNF in SE and in its consequences. However, these NTFs have been found to exert some contrasting effects, for example, to favor seizures but protect from cell damage. A better understanding of the mechanisms of FGF-2 and BDNF biosynthesis and signaling will be therefore instrumental for the development of therapeutic strategies that are not compromised by paradoxical side effects.
| INTRODUCTION
Neurotrophic factors (NTFs) are molecules that support the growth, survival, and differentiation of developing and mature neurons. In the adult nervous system they do not only produce these neurotrophic effects, but also exert functional effects at the synaptic level, with distinct modulatory actions at excitatory and inhibitory synapses. 1 These biologic features prompt the hypothesis that NTFs may be involved in some aspects of status epilepticus (SE), like cell death and circuit rearrangements, and of possible consequences of SE, like epileptogenesis. Although many different NTFs have been investigated on the basis of this hypothesis, including glial cell-derived neurotrophic factor, 2,3 nerve growth factor (NGF), 4, 5 and vascular endothelial growth factor (VEGF), 6 ,7 the most compelling evidence supports a particularly strong involvement of fibroblast growth factor 2 (FGF-2) and, most of all, of brain-derived neurotrophic factor (BDNF). In this article, I will focus on these 2 NTFs. I will first summarize their biologic features and then describe existing evidence supporting their implication in SE and its outcomes.
| BIOLOGY OF FGF-AND BDNF

| Fibroblast growth factor 2
Fibroblast growth factor 2 belongs to a family of structurally related proteins, the FGFs, that encompasses 22 members in humans and mice. 8 Most FGFs are secreted proteins, but the family also includes 4 members that exert purely intracrine effects. 9 The 25 Neurotrophins are critical for the development and functioning of the nervous system. Although originally identified as neuronal survival factors, they elicit many biologic effects, ranging from proliferation to synaptic modulation to axonal pathfinding. As many as 11 different BDNF transcripts can be generated in both humans and rodents by alternative splicing. 26 These transcripts differ only in their 5′ untranslated region (UTR) but share a common coding region and 3′ UTR. All these messenger RNAs (mRNAs) are expressed in the brain with a district spatial distribution, as expression levels varies in different neuronal populations. [26] [27] [28] BDNF is known to exert multiple important effects on the central nervous system. It increases survival of adult neurons; it is a key factor for the neuronal differentiation of neural progenitor cells; and it is implicated in plastic changes at structural and synaptic level (for example, dendritogenesis and potentiation of excitatory synapses). 33, 34 In sum, FGF-2 seems to favor the generation of seizures while attenuating their consequences (seizureinduced damage). BDNF has been also implicated in seizures (its implication in epileptogenesis will be discussed below): (1) seizures massively increase BDNF expression and activate TrkB receptors 30, [35] [36] [37] ; (2) BDNF has been reported to enhance excitatory synaptic transmission 38 and reduce γ-aminobutyric acid (GABA)ergic inhibitory synaptic transmission in the rat hippocampus, 39 but also to reduce GABA receptor desensitization (I GABA rundown) in human and rat epileptic hippocampus. 40, 41 Based on these data, it remains unclear if BDNF may exert pro-or anti-seizure effects, or both. To explore directly the possible implication of FGF-2 and BDNF in SE, we and others altered (either increased or decreased) the endogenous levels of these NTFs in key brain areas (primarily the hippocampus) and evaluated the severity of chemoconvulsant-induced SE.
To evaluate the implication of FGF-2 in SE we used FGF-2 transgenic mice (TgFGF2). 42 These mice display increased FGF-2 expression in hippocampal pyramidal and granule neurons. Moreover, TgFGF2 mice have an increased density of glutamatergic synaptic vesicles in the hippocampus, and increased excitatory inputs in CA1 pyramidal cells, suggesting the presence of a latent hyperexcitability. Indeed, TgFGF2 mice displayed increased susceptibility to kainate-induced SE compared with wildtype (WT) littermates (reduced latency to generalized
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• Neurotrophic factors may be involved in status epilepticus and in its consequences • This hypothesis has been explored mainly for fibroblast growth factor 2 (FGF-2) and brainderived neurotrophic factor (BDNF) • However, FGF-2 and BDNF have been found to exert some contrasting effects, for example, to favor seizures but protect from cell damage • A better understanding of the biology of FGF-2 and BDNF is needed to dissect their potential therapeutic from their possible side effects seizure onset, increased behavioral seizure scores and increased lethality). WT and TgFGF2 mice with similar SE severity were used for examining SE-induced cellular outcomes. Neurogenesis and mossy fiber sprouting were not significantly different between the 2 groups. In contrast, cell damage (assessed with Fluoro-Jade B, silver impregnation, and anti-caspase 3 immunohistochemistry) was significantly lower in TgFGF2 mice, especially in the areas of overexpression (CA1 and CA3). These observations suggest a reduction in seizure-induced cell death. Another research group reported that the sensitivity to kainate-induced SE in FGF-2 knockout mice was similar to that observed in WT animals. 23 Thus, FGF-2 does not seem to be necessary for the occurrence of SE but can potentiate it. In addition, and in apparent contrast with the above, FGF-2 reduces SE-induced cell death.
| Brain-derived neurotrophic factor
The implication of BDNF in SE has been evaluated inducing kainate SE in transgenic mice with increased BDNF signaling due to TrkB overexpression. 43 These mice experienced a more severe SE and had increased acute hippocampal neuronal loss compared with WT animals, supporting a role of BDNF in seizure generation and acute cellular damage after SE. Of course, studies in conventional adult transgenic and knockout mice can be difficult to interpret because developmental compensations may have occurred that obscure relevant effects. Therefore, we thought to integrate these findings by developing tools to silence the BDNF signal in adults and in a confined brain area. To pursue this goal, we used herpes simplex virus type 1-derived amplicon vectors. Amplicons are nonpathogenic viral particles containing a large genome (152 kb) constituted of concatemeric repetitions of an expression cassette, thus enabling the expression of the gene of interest in multiple copies. This represents an ideal choice for expressing a silencing cassette, which could thereby lead to a highly efficient knockdown of the expression of the target gene. We inserted in an amplicon multiple copies of the BDNF gene in antisense direction, to target and degrade the cytoplasmic mRNA pool of BDNF. 44 This amplicon vector proved effective in downregulating BDNF expression in vitro and in vivo. Moreover, the knocking down of BDNF mRNA levels produced significant effects on pilocarpine-induced SE. Animals treated with BDNF-antisense entered convulsive SE later than those treated with a control vector, but the percentage of animals that died after SE was higher in the BDNF-antisense group. These findings support the notion that BDNF increases the severity of SE but, at the same time, may exert a neuroprotective effect that reduces SE-induced mortality.
| IMPLICATION OF BDNF IN SE-INDUCED EPILEPTOGENESIS
The controversies on the implication of BDNF in SE extend to the outcomes of SE. Many studies support the notion that BDNF plays a pro-epileptogenic role, because different approaches aimed at downregulating the BDNF signal retard epileptogenesis. 37, [45] [46] [47] In contrast, however, the combined supplementation of BDNF and FGF-2 has been reported to attenuate the cellular alterations associated with epileptogenesis and to highly significantly reduce the frequency and severity of spontaneous recurrent seizures.
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| CONCLUSIONS: HOW TO HANDLE DOUBLE-EDGE SWORDS
In conclusion, there is convincing evidence of an implication of FGF-2 and BDNF in SE and in its consequences. However, these NTFs seem to behave as double-edge swords, their main contrasting effects being that they favor seizures but protect from cell damage. Therefore, understanding in detail the mechanisms of FGF-2 and BDNF biosynthesis and signaling, and finding ways to interfere selectively with specific aspects of their biology, will be essential to develop therapeutic strategies that are not compromised by unwanted (or even paradoxical) side effects. In this respect, recent experimental evidence began to shed some light on the mechanisms underlying the contrasting effects of BDNF. These may depend on a number of factors: alternative splicing of BDNF mRNA, processing of the pro-into the mature form, specific cellular domain of action, receptor subtype (high-or low-affinity) involved in the effect, and signaling pathways activated by interaction with the receptor. 29 One interesting possibility is the regulation of the local availability of BDNF. A physiologic mechanism to deliver BDNF at distinct subcellular locations is the generation of different mRNA splices variants and differential trafficking of these mRNA within the neurons. As noted above, different BDNF transcripts can be generated by alternative splicing, and expression of all these BDNF mRNAs is independently regulated by different promoters. 26, 27, 51 We found that SE induces the dendritic targeting of some BDNF mRNA splice variants, whereas others remain confined to the cell body. 52, 53 This implies that the BDNF protein may be synthesized at distinct neuronal sites (near synaptic contacts vs soma), producing distinct effects (potentiation of excitatory synapses vs neurotrophic effects and pro-vs antiepileptic effects). This hypothesis is amenable to experimental testing by using viral amplicon vectors expressing antisense mRNAs SIMONATO | 89 directed specifically against either the dendritic or the somatic splice variants.
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